Cytokinetics
CYTK
CYTK
390 hedge funds and large institutions have $8.26B invested in Cytokinetics in 2024 Q1 according to their latest regulatory filings, with 105 funds opening new positions, 128 increasing their positions, 120 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% more call options, than puts
Call options by funds: $507M | Put options by funds: $485M
4.67% less ownership
Funds ownership: 119.02% → 114.35% (-4.7%)
15% less capital invested
Capital invested by funds: $9.74B → $8.26B (-$1.49B)
Holders
390
Holding in Top 10
22
Calls
$507M
Puts
$485M
Top Buyers
| 1 | +$349M | |
| 2 | +$224M | |
| 3 | +$162M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$149M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$127M |
Top Sellers
| 1 | -$298M | |
| 2 | -$285M | |
| 3 | -$194M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$163M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$137M |